Afinitor Oral Tablet 7.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

Afinitor: Oral tablet (7.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Most Commonly Used
Drug Image file default-drug-image.png
Afinitor 7.5mg Tab

What is this Medicine?

EVEROLIMUS (eve ROE li mus) decreases the activity of your immune system. Afinitor is used to treat certain types of cancer. Zortress is used for kidney and liver transplant rejection prophylaxis.

CVS/pharmacy Patient Statistics for Afinitor: Oral tablet(7.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Afinitor 7.5mg Tablet

NDC: 000780620
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer, Pancreatic Neuroendocrine Tumor (PNET), Liver Transplant Rejection Prophylaxis, Kidney Transplant Rejection Prophylaxis, Renal Cell Cancer, Astrocytoma, Renal Angiomyolipoma

Storage Information
Protect from light
Store in original container
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Afinitor 7.5mg Tablet

Reported Side Effects for Afinitor 7.5mg Tablet

High Bilirubin Level Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<4.2%*
Severity: SEVERE
Onset: DELAYED
Decreased Healing Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Hemolytic-uremic Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<4.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<4.2%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
<15.0%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<17.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Yeast Infection Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
0.2-1.0%*
Severity: SEVERE
Onset: RAPID
Inability To Sleep Incidence:
0.2%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
0.2-6.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
0.2-1.0%*
Severity: SEVERE
Onset: DELAYED
Metallic Taste Incidence:
0.2%*
Severity: SEVERE
Onset: EARLY
Constipation Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
0.4-1.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
0.4-2.0%*
Severity: SEVERE
Onset: EARLY
Migraine Incidence:
0.5%*
Severity: SEVERE
Onset: EARLY
Lightheadedness Incidence:
0.5%*
Severity: SEVERE
Onset: EARLY
Weight Loss Incidence:
0.5-1.0%*
Severity: SEVERE
Onset: DELAYED
Onycholysis Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
0.6%*
Severity: SEVERE
Onset: DELAYED
High Cholesterol Incidence:
0.8-1.0%*
Severity: SEVERE
Onset: DELAYED
High Triglycerides Incidence:
0.8%*
Severity: SEVERE
Onset: DELAYED
Low Albumin In Blood Incidence:
0.8-1.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
0.8-1.5%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Osteopenia Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Paresis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Pus In Urine Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Kidney Failure Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Difficulty Swallowing Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Cataracts Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Gingival Hyperplasia Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Cushingoid Features Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Conjunctivitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Chest Pain Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Of Blood Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Bruise Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Drug-Induced Acne Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: EARLY
Ambras Syndrome Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Hypoesthesia Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Kidney Inflammation Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Cyst Of Lymph Fluid Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Lymphocytes Incidence:
1.0-18.0%*
Severity: SEVERE
Onset: DELAYED
Wound Dehiscence Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: EARLY
Bowel Obstruction Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Low Phosphate Level Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Dead Bone Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
1.0-37.0%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Depression Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Hirsutism Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Hemorrhoids Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Gout Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Hair Follicles Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Gas Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-5.5%*
Severity: SEVERE
Onset: EARLY
Nose Bleed Incidence:
1.0-22.0%*
Severity: MILD
Onset: DELAYED
Night Sweats Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Nervousness Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Wheezing Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Urinary Urgency Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Bladder Spasm Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: DELAYED
Sinus Infection Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Fluid In Lungs Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: EARLY
Protein In The Urine Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Around The Lungs Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
1.0-11.0%*
Severity: MILD
Onset: DELAYED
Osteoporosis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Stuffy Nose Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
1.5%*
Severity: SEVERE
Onset: DELAYED
Diabetes Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
2.2-3.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
2.5%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
2.5-7.0%*
Severity: SEVERE
Onset: EARLY
Bladder Infection Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Prolonged Bleeding Time Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Dehydration Incidence:
>3.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Feeling Sick Incidence:
3.5%*
Severity: SEVERE
Onset: EARLY
Tired Incidence:
3.5-5.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
4.0%*
Severity: MODERATE
Onset: EARLY
Mouth Sores Incidence:
4.0-9.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
4.0-9.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Low Potassium Levels Incidence:
4.2%*
Severity: SEVERE
Onset: DELAYED
Hand And Foot Syndrome Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
5.0-10.0%*
Severity: SEVERE
Onset: DELAYED
High Potassium Level Incidence:
7.0-18.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
8.0-11.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
10.0-22.0%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
11.0%*
Severity: MODERATE
Onset: EARLY
Blood In The Urine Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Low Magnesium Levels Incidence:
14.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
21.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Afinitor 7.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Afinitor 7.5mg Tablet(Everolimus)
Grapefruit juice and Everolimus(Everolimus)
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Afinitor

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5